Join to View Full Profile
1470 Madison AvenueNew York, NY 10029
Phone+1 212-824-9331
Dr. Parsons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stony Brook University Health Sciences Center School of MedicineClass of 1992, MD
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1999
Publications & Presentations
PubMed
- 38 citationsDesign, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders.Xufen Yu, Jia Xu, Ling Xie, Li Wang, Yudao Shen
Journal of Medicinal Chemistry. 2021-12-02 - 40 citationsAKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B.Jia Xu, Xufen Yu, Tiphaine Martin, Ankita Bansal, Kakit Cheung
Cancer Discovery. 2021-07-23 - 22 citationsNOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.Kyrie Pappas, Tiphaine Martin, Andrew Wolfe, Christie B. Nguyen, Tao Su
Communications Biology. 2021-03-09
Journal Articles
- Mouse ER+/PIK3CAH1047R Breast Cancers Caused by Exogenous Estrogen Are Heterogeneously Dependent on Estrogen and Undergo BIM-Dependent Apoptosis with BH3 and PI3K AgentsMatthias Szabolcs, Ramon Parsons, Hank Schmidt, Nature
Press Mentions
Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at the Mount Sinai HospitalMarch 15th, 2023- Newly Developed Therapeutic Agent Can Be Effective for Various Cancer TypesJanuary 26th, 2023
- New Gene Essential to Colon Cancer Growth IdentifiedOctober 18th, 2022
- Join now to see all
Grant Support
- THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2015–2025
- Mutual Regulation Of PTEN And P-Rex2a In Normal And Cancer CellsNational Cancer Institute2011–2012
- Oncogenic Role Of PIK3CA Hotspot MutationsNational Cancer Institute2009–2012
- The Role Of PTEN In Basal-Like Breast CancerNational Cancer Institute2011
- Administrative And Analytical CoreNational Cancer Institute2011
- Molecular Pathogenesis Of Basal-Like Breast CancerNational Cancer Institute2009–2011
- Breast Cancer ResearchNational Cancer Institute2008–2011
- PTEN Tumor Suppressor And Signal TransductionNational Cancer Institute2001–2010
- PI-3 Kinase Therapy In Mouse Tumor ModelsNational Cancer Institute2002–2005
- Characterization Of The 10q22-23 Candidate Tumor Suppressor In Breast CancerNational Cancer Institute1998–2001
- Colorectal Specific Gene ExpressionNational Cancer Institute1992–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
